Skip to main content
Explore URMC
menu

Nicholas Erick Nacca, M.D.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentNot Accepting New Patients

Biography

Professional Background

Dr. Nacca was born Rochester NY. He completed his undergraduate work at University of Rochester with a Bachelor of Science in Neuroscience. He completed medical school, Emergency Medicine residency training, and Medical Toxicology fellowship at SUNY Upstate Medical University and the Upstate Poison Control Center. He currently works as an Emergency Physician and Medical Toxicologist at University of Rochester Medical Center where he serves as the Director of Medical Toxicology. The Medical Toxicology consult service at URMC provides 24/7 call coverage for Strong Memorial Hospital and affiliates, fielding both inpatient and outpatient consultations for management of both intentional and unintentional ingestions, overdoses, and environmental exposures. Dr. Nacca’s focus is on Medical Toxicology and Emergency Medicine education, with interest in novel psychoactive substances and adulterated drugs of abuse.

Credentials

Specialties

    Education

    2010
    MD | SUNY Upstate College of Health Professions

    Post-doctoral Training & Residency

    06/01/2013 - 06/30/2015
    Fellowship in Medical Toxicology at SUNY Upstate Medical University

    07/01/2011 - 06/30/2013
    Residency in Emergency Medicine at SUNY Upstate Medical University

    07/01/2010 - 06/30/2011
    Internship in Emergency Medicine at SUNY Upstate Medical University

    VIEW ALL expand_more

    Publications

    Journal Articles

    2/11/2023
    Choe AJ, Ellison R, Ramaswamy SR, Schult RF, Gerona R, Nacca N. "Profound Hyperthermia Associated With Fentanyl and Cocaine Use With Suspected Synephrine Adulteration." The Journal of emergency medicine.. 2023 Feb 11; Epub 2023 Feb 11.

    2/28/2022
    McGraw MD, Croft DP, Nacca NE, Rahman I. "Reduced Plasma Phosphatidylethanolamines in E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI)." Pediatric pulmonology.. 2022 Feb 28; Epub 2022 Feb 28.

    11/19/2021
    Schult RF, Nacca N, Grannell TL, Jorgensen RM, Acquisto NM. "Evaluation of high-dose insulin/euglycemia therapy for suspected ?-blocker or calcium channel blocker overdose following guideline implementation." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2021 Nov 19; Epub 2021 Nov 19.

    VIEW ALL PUBLICATIONS